Brain and Spinal Cord Repair Flashcards

1
Q

What are spinal cord injuries usually caused by? (19:55)

A
  • 38.5%; car accidents
  • 24.5%; violent encounters e.g. guns/knives
  • Rest; sporting accidents, falls, work-related accidents
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the demographic like for spinal cord injury?

A
  • 55% of patients are between 16 and 30 years old

- > 80% of patients are male

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the typical progression like of CNS injury WRT the spinal cord?

A
  • Local swelling at the site of injury; punches off blood perfusion = ischaemia (secondary problem)
  • Excessive release of Glu and excitotoxicity of neruons and oligodendrocytes at site of injury
  • Infiltration by immune cells (microglia, neutrophils) = scar tissue (bad)
  • Free radical (NOS etc.) toxicity
  • Apoptosis/necrosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the restructuring that occurs in response to damage in the CNS?

A
  • Astrocytes begin production and secretion of cytokines; ‘reactivates’ proliferation.
  • Infiltrate the lesion and form a scar
  • Astrocytes expresses a complex milieu of proteoglycans (chondroitin sulfate proteoglycans) at the scar boundary
  • Damage to axons in the CNS results in retraction of resealed growth cone where it stalls indefinitely; scar tissue blocks axon regeneration
  • Axons are demyelinated and degenerate, or remain ‘fixed’ in place for years.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Explain why the regeneration of axons and resulting functional recovering occurs in the peripheral nervous system, but not the CNS.

A

Two entities within the CNS are responsible for the CNS-specific hostile environment:

1) Reactive astrocytes
2) Oligodendrocyte myelin-associated inhibitors e.g. Nogo, MAG, OMgp, chondroitin sulfate proteoglycans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the symptoms of spinal cord injury?

A
  • Involuntary muscle spasms
  • Loss of:
    • Voluntary movement
    • Sensation
    • Balance
    • Control of breathing
    • Autonomic functions (BP)
    • Bladder
    • Sexual
    • Bowel control
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the symptoms of spinal cord attributed to? What must occur to repair these pathways?

A
  • Destruction of long ascending or descending spinal pathways

To repair:

  • Axons must regrow
  • Synaptic circuits must be re-established
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the requirements for restoring function to CNS neurons? Methods?

A
  • Transection of the cord is rare (complete tear)
  • <10% axons can support substantial functional recovery
  • Even ‘complete’ injuries recover some function
  • Surviving axons need to be myelinated; scar tissue leads to progressive degeneration
    > 4-aminopyridine improves conduction
    > Stem and other cells remyelinate spinal axons
  • Reversing learned “non-use”
    > Even a short period of non-use can turn off circuits
    > Intensive “forced use” exercises required to restore function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the principles of neuron response to injury?

A
  • If the cell body is damaged, the neuron dies and is not replaced by cell division in the adult, mature brain
  • If the axon is damaged or severed at a distance from the soma (cell body), there is a good chance of regeneration (primarily in the PNS); the further away the better
  • CNS neurons have the CAPACITY to regenerate
  • Presynaptic and postsynaptic neurons are also affected and may degenerate; chain reaction downstream
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the historical treatment of CNS injury (1920s+).

A
  • Development of X-ray technologies in 1920s allowed visualisation of spinal injuries and more accurate prognosis of outcomes
  • By middle of 20th century, standard to stabilise injuries, fix them in place, rehabilitate disabilities w/exercise
  • 1990s; anti-inflammatory steroid methylprednisolone used to minimise cell death and tissue damage, if administered early enough after injury
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are today’s principles regarding how to tackle CNS damage?

A

Fix what’s left:

  • Prevent cell death
  • Promote axon regrowth
  • Remove blockages

Build around it:
- Brain-machine interfaces that interpret neural codes and output activity to periphery (organic or machine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What surgical advances have been made WRT treating CNS damage?

A

Decompression and stabilisation of the spine:

  • Anterior and posterior plates
  • Titanium cage vertebral repair
  • Delayed decompression restores function even years after injury

Urological procedures:

  • Suprapubic catheterisation
  • Mitrafanoff procedure; use of appendix to allow catheterising the bladder through belly button
  • Vocare sacral stimulation

Syringomyelic cysts:

  • Removing adhesions and untethering of the cord collapses syringomyelic cells with lower rate of recurrence
  • Restoring CSF flow is key to preventing cyst development

Peripheral nerve bridging (most useful):

  • Implanting avulsed roots or nerves into the spinal cord; bypassing injury site (muscle reinnervation, reduced neuropathic pain)
  • Bridging nerves from above the injury site to organs below
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How can drugs promote CNS regeneration?

A
  • Inhibiting the axon regeneration blockers in CNS myelin
  • Removing barriers formed by glia scars
  • Stimulating regrowth by signalling pathways
  • Replacement of neurons damaged during injury with embryonic stem cells
  • Engineering brain-machine interfaces to produce enhanced sensory feedback prosthetics (bionic/cybernetics)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the timeline of understanding of Neural Regeneration?

A
  • 1830s; First evidence of regeneration of severed sciatic nerve in rabbits
  • 1890s; CNS nerves appear to attempt to regenerate but can’t; introduce ‘hostile CNS environment’ concept
  • 1969; Neurons demonstrated to establish new synapses and reorganise networks after injury
  • 1982; Crushed peripheral rat axons shown to grow in rat brain in the presence of its peripheral nerve graft, but stalls upon reaching the boundary of the CNS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What types of glial cells are there?

A
  • Myelin-forming (Oligodendrocytes of CNS, Schwann cells of PNS)
  • And astrocytes (non-myelin forming)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How do Schwann cells and oligodendrocytes differ WRT axon regrowth?

A
  • Schwann cells (PNS); supportive, growth surface and releaser of growth factors
  • Oligodendrocytes (CNS); inhibitory to axon regrowth in adult CNS regeneration.
17
Q

What is the function of astroglia during its development, once mature, and if injured?

A

Development:
- Supports axon growth and cell migration

Mature:
- Important for ion influx, synaptic function, cell migration

Injury:
- Accumulate in scar, release excess matrix, inhibit axos growth

18
Q

Do microglia (resting) and macrophages (active) act to help or hinder if injured?

A
  • Cells of immune system, similar to monocytes

- Not well understood if help or hinder

19
Q

Describe the reactions to injury within the neuron, on a time-scale.

A

Immediately:

1) Synaptic transmission off
2) Cut ends pull apart and seal up, swelling due to axonal transport in both directions

Hours:

3) Synaptic terminal degenerates; accumulation of neurofilaments, vesicles
4) Astroglia surround terminal normally; after axotomy, astroglia interpose between terminal and target as terminal to be pulled away from postsynaptic cell

Days/weeks:

5) Myelin breaks up and leaves debris (myelin hard to break down)
6) Axon undergoes Wallerian degeneration
7) Chromatolysis; cell body swells, nissl and nucleus eccentric.
8) Transneuronal degeneration (retro/anterograde); pre/post-synpatic neurones either side of damaged neuron affected by injury too

> > > Changes same for PNS or CNS

20
Q

Why do CNS axons have a limited capacity to regenerate?

A

Growth impeded by negative elements in the environment:

  • Myelin proteins (NOGO, MAG, Omgp) increase
  • Extracellular matrix (laminin) is sparse; inhibitory proteoglycans (from glia) increase
  • Growth factors have different distributions compared to young brain
  • Intracellular growth elements e.g. GAP-43 (important for intracellular signalling/growth cone advance) are low
  • Glial cells inhibit growth; oligodendrocytes (myelin of CNS) most inhibitory
  • Astrocytes accumulate in scar around injury site
  • Macrophages also accumulate; role of microglia unclear
21
Q

What evidence is there outlining myelin’s role as a regeneration inhibitor?

A
  • Immunisation of rats against myelin promotes regeneration of axons through spinal cord lesion
22
Q

What is the significance of IN-1?

A
  • Myelin-inhibitor antibody
  • IN-1 addition to culture allows axon outgrowth on myelin
  • Helped identify Nogo, the first myelin-associated inhibitor
  • IN-1 treatment after injury also results in functional recovery of motor coordination in feeding test
23
Q

What is Nogo?

A
  • Reticulon family protein
  • Three isoforms: Nogo-A, Nogo-B, Nogo-C; expressed from differential splicing and alternative promoter usage (Nogo-C)
  • C-terminus contains two hydrophobic regions thought o be TM sequences, required for ER membrane localisation in other reticulons
  • Localised to the plasma membrane, endoplasmic reticulum, neuronal synapses
  • Nogo-A in CNS, Nogo-B in the CNS/lung/liver, Nogo-C in the skeletal muscle
24
Q

What is MAG?

A
  • Myelin-Associated Glycoprotein (MAG)

- Transmembrane protein with 5 immunoglobulin-like repeats in the extracellular domain

25
Q

What is OMgp?

A
  • Oligodendrocyte Myelin Glycoprotein (OMgp)

- GPI-linked containing leucine-rich repeat (LRR) domains w/serine/threonine repeats

26
Q

What is the Nogo Receptor (NGR) a receptor for? What is its coreceptor?

A
  • For Nogo, MAG and OMgp
  • GPI-linked protein with LRR repeats
  • Has no transmembrane motifs; requires a coreceptor to transmit its signal across the membrane
    »> p75 neurotrophin receptors acts as coreceptor
    »> Lots of research to specifically inactivate this receptor as NGR is convergent
27
Q

Why are CSPGs (chondroitin sulfate proteoglycans) an attractive drug target?

A
  • CSPGs upregulated in the glial scar following spinal cord lesion
  • Treatment with chondroitinase (cleaves CSPG from surface of the cell) enhances regrowth through lesion
  • Measuring electrical activity at various points in the spinal cord and stimulating the cortex showed that severed neurons reestablish their connectivity.
28
Q

What pathway regulates MAG signalling?

A
  • cAMP pathway
  • cAMP levels drop in CNS during development, but high at birth
  • Negative effect of MAG countered by cAMP pathway
    »> Activation of cAMP signalling enhances regeneration
29
Q

Describe stem cell approaches for CNS Repair.

A
  • Transplantation of oligodendrocyte progenitor cells to treat myelination disorders
  • Transplantation of phenotypically restricted (unipotent) neuronal progenitors to treat neurodegeneration
  • Implantation of mixed progenitor pools or multipotent stem cells to reconstruct disorders w/losses of several lineages (produces cells locally that are desired)
  • Mobilisation of endogenous neural precursors to replace neuronal loss in disease
30
Q

What are the regenerative therapies availible?

A
  • Axonal growth inhibitor blockage (e.g. Humanised IN-1 blocking Nogo)
  • Axonal growth factors (e.g. Adenosine)
  • Therapeutic vaccines (e.g. Spinal cord homogenate vaccine)
  • Cell transplants (e.g. embryonic/foetal stem cells, activated macrophages)
  • Cell adhesion molecules
  • Axonal growth messengers (e.g. increased cAMP)
  • Electrical stimulation
31
Q

What remyelinative therapies are availible?

A
  • Schwann cell transplants
  • Oligodendroglial cell transplants
  • Stem cells
  • Olfactory ensheathing glia (OEG) transplants
  • Antibody therapies e.g. M1 antibody
32
Q

What new scientific trends are there WRT to regenerative/remyelinative therapies?

A
  • High volume drug screening
  • Gene expression studies (e.g. GM stem cells delivering growth factors and genes to spinal cord)
  • Recombinant molecular and gene therapies
  • Immunotherapies (activated macrophages/T-lymphocytes, therapeutic vaccines to stimulate endogenous Ab production)